ESTRO 2024 - Abstract Book
S1336
Clinical - Head & neck
ESTRO 2024
Age
68 years
69 years
-
Median (range)
(43 to 94yrs)
(51 to 91yrs)
Age
< 70 years
60 (57.1%)
32 (55.2%)
Table 1: Comparison of patient characteristics between radiotherapy dose groups. The p-values for gender, age and history of smoking were calculated with the Chi square test. Tumour staging as per TNM Classification of Malignant Tumours 8th Edition.* p value for stage is calculated with Fisher’s exact test.
0.808
≥ 70 years
45 (42.9%)
26 (44.8%)
History smoking
of
90 (81.8%)
56 (88.9%)
Yes
0.218
20 (18.2%)
7 (11.1%)
No
Stage
Tis
7 (6.4%)
0 (0%)
<0.001*
T1
98 (89.1%)
2 (3.2%)
T2
5 (4.5%)
61 (96.8%)
Follow-up duration
64 months
54 months
-
(3 to 161)
(0 to 160)
Median (range)
Figure 1: Kaplan Meier curve showing DSS. Censor points defined as date last seen alive or death from non-larynx cause.
Made with FlippingBook - Online Brochure Maker